Philadelphia Avandia Attorneys

Avandia

Avandia, a medication which is prescribed to treat type II diabetes, has been linked to an increased risk of heart attack, heart disease and death. Avandia, which has been on the market for over ten years, is used to control blood sugar levels. In May 2007, concerns were raised about Avandia's safety. Initially, the concerns were related to heart disease, but more recent studies have suggested that in certain individuals, Avandia may also cause liver failure, bone fractures and blindness.

Currently, there is a movement to recall Avandia. A consumer protection group, Public Citizen, has petitioned the FDA to ban Avandia as a dangerous drug, because its risks outweigh its benefits and safer alternatives are available. Although it is unclear when the FDA will act on Public Citizen's petition, the American Diabetes Association and the European Association for the Study of Diabetes are both advising against the use of Avandia. Even though the number of prescriptions for Avandia fell sharply after the dangers were revealed, over 4.5 million prescriptions for this dangerous drug were filled in the last year.

If you or anyone you love has suffered any of the side effects listed above after taking the oral contraceptive known as Avandia please contact Stacy Mogul at 267-820-9002, or complete the contact form provided on this site to schedule a free consultation.

 

Contact Heiligman & Mogul, P.C. - Solid Legal Advice is only one Email Away

Please explain your legal situation.


* Please enter the security code shown below:

Captcha Image

      

LawInfo Lead Counsel Rated Attorney

This is a paid advertisement.
By submitting a question, you agree to our terms and conditions.

Philadelphia Personal Injury Lawyers - Disclaimer

Coverage Areas: Philadelphia, Chester County, Delaware County, Montgomery County, Bucks County
Lead Counsel Program | Site Map
Copyright 2012 LawInfo.com, Inc. All rights are reserved.
No portion of this site may be reproduced in any manner in any medium without the express written consent of LawInfo.com, Inc.